GLP-2 (T)
GLP-2 (T)
A dual GIP/GLP-1 receptor agonist By activating both GIP and GLP-1 pathways simultaneously, it achieves superior weight loss vs. semaglutide alone. Improves insulin secretion, reduces appetite, and enhances fat metabolism.
Price range: $ 30 through $ 300
✓ Superior weight loss (up to 22–25% body weight)
✓ Better glycemic control than GLP-1 monotherapy
✓ Improved triglycerides and HDL cholesterol
✓ Reduced liver fat
✓ Cardiovascular benefit signals in trials
5 Days
